Literature DB >> 16765989

Vascular parkinsonism--an update.

Ivan Rektor1, Irena Rektorová, Dagmar Kubová.   

Abstract

Vascular parkinsonism (VP) is a heterogeneous clinical entity. The idea of a relationship between cerebral vascular disease and parkinsonism may be traced back to the 1920s, when the diagnostic unit called "arteriosclerotic parkinsonism", a predecessor of VP, was established. This review is concerned with historical and contemporary views regarding the possible vascular genesis of parkinsonism. Confusion persists as a result of vaguely defined diagnostic criteria. The following types of simultaneous occurrence of parkinsonism and cerebral vascular disease (CVD) may be recognised: 1. gait disorders of the lower body parkinsonism type are caused mostly by white matter lesions in the frontal lobes; such disorders may require a diagnosis of vascular origin. We suggest replacing the term "lower body parkinsonism" with a more appropriate term not including the word "parkinsonism": an alternative term could be "cerebrovascular gait disorder"; 2. if the signs and symptoms are typical for idiopathic Parkinson's disease (IPD), the coincidence of IPD and CVD should be considered; 3. if the symptoms of parkinsonism are neither typical for IPD nor for VP, and there are clinical or MR signs of CVD, VP should be regarded as possible when alternative causes are excluded; 4. if the symptoms of parkinsonism and clinical and MR signs are typical for VP, VP should be regarded as probable; 5. if a stroke affecting the contralateral basal ganglia is followed by the occurrence of hemiparkinsonism, the diagnosis of VP is unambiguous. Vascular parkinsonism (VP) is probably one of the most frequently erroneous neurological diagnoses. The reason for this misdiagnosis is that both cerebral vascular disease (CVD) and parkinsonism usually occur at the same age. Due to the high incidence of CVD, it is possible for CVD and idiopathic Parkinson's disease (IPD) to coincide in some cases. Another reason for the misdiagnosis is that the concept of VP lacks clarity. This review aims to contribute to an improved understanding of VP in clinical practice. In this context, the term "CVD" is understood in the broad sense of a brain impairment caused by cerebral vessel pathology. It covers various concepts, as some authors use the term CVD to mean a manifestation of vascular lesions in pathologico-anatomical material or in the imaging techniques; others mean the history and clinical manifestation of cerebral ischaemia, or, more rarely, haemorrhage. The term CVD may cover large vessel disease as well as small vessel disease. This means that territorial and lacunar infarcts and white matter lesions (WML) are all considered as CVD.

Entities:  

Mesh:

Year:  2006        PMID: 16765989     DOI: 10.1016/j.jns.2006.05.026

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  16 in total

Review 1.  The clinical manifestations and pathophysiology of cerebral small vessel disease.

Authors:  Ai-Juan Zhang; Xin-Jun Yu; Mei Wang
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

Review 2.  The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.

Authors:  Branislav Veselý; Angelo Antonini; Ivan Rektor
Journal:  J Neural Transm (Vienna)       Date:  2015-10-19       Impact factor: 3.575

3.  Parkinson's disease and cerebrovascular disease: is there a link? A neurosonological case-control study.

Authors:  Sandro Zambito Marsala; Manuela Gioulis; Michele Pistacchi; Cecilia Lo Cascio
Journal:  Neurol Sci       Date:  2016-07-09       Impact factor: 3.307

Review 4.  An updated diagnostic approach to subtype definition of vascular parkinsonism - Recommendations from an expert working group.

Authors:  Ivan Rektor; Nicolaas I Bohnen; Amos D Korczyn; Viktoria Gryb; Hrishikesh Kumar; Milica G Kramberger; Frank-Erik de Leeuw; Zvezdan Pirtošek; Irena Rektorová; Ilana Schlesinger; Jaroslaw Slawek; Peter Valkovič; Branislav Veselý
Journal:  Parkinsonism Relat Disord       Date:  2017-12-29       Impact factor: 4.891

5.  Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies.

Authors:  Irene Marzona; Martin O'Donnell; Koon Teo; Peggy Gao; Craig Anderson; Jackie Bosch; Salim Yusuf
Journal:  CMAJ       Date:  2012-02-27       Impact factor: 8.262

6.  Machine learning models for the differential diagnosis of vascular parkinsonism and Parkinson's disease using [(123)I]FP-CIT SPECT.

Authors:  I Huertas-Fernández; F J García-Gómez; D García-Solís; S Benítez-Rivero; V A Marín-Oyaga; S Jesús; M T Cáceres-Redondo; J A Lojo; J F Martín-Rodríguez; F Carrillo; P Mir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-14       Impact factor: 9.236

7.  Midbrain atrophy in vascular Parkinsonism.

Authors:  Seong-Min Choi; Byeong C Kim; Tai-Seung Nam; Joon-Tae Kim; Seung-Han Lee; Man-Seok Park; Myeong-Kyu Kim; Mony J de Leon; Ki-Hyun Cho
Journal:  Eur Neurol       Date:  2011-04-21       Impact factor: 1.710

8.  Subtype definition of vascular parkinsonism.

Authors:  Ivan Rektor; Nicolaas I Bohnen; Amos D Korczyn
Journal:  Parkinsonism Relat Disord       Date:  2018-03-09       Impact factor: 4.891

Review 9.  Substrates for normal gait and pathophysiology of gait disturbances with respect to the basal ganglia dysfunction.

Authors:  Kaoru Takakusaki; Nozomi Tomita; Masafumi Yano
Journal:  J Neurol       Date:  2008-08       Impact factor: 4.849

10.  Dopaminergic degeneration is enhanced by chronic brain hypoperfusion and inhibited by angiotensin receptor blockage.

Authors:  Ana I Rodriguez-Perez; Antonio Dominguez-Meijide; Jose L Lanciego; Maria J Guerra; Jose L Labandeira-Garcia
Journal:  Age (Dordr)       Date:  2012-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.